Insights, Updates & Access Guides | 24/7 QualityMeds Blog

October 1, 2025

COLUMVI (glofitamab-gxbm) is an innovative prescription medicine approved for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and large B-cell lymphoma (LBCL) who have already received two or more prior lines of therapy.

This treatment provides a new therapeutic option for patients with limited alternatives. The current approval of Columvi is conditional, based on response rates and durability of response in clinical studies. Ongoing research continues to evaluate its long-term effectiveness and safety.

It is important to note that the safety and effectiveness of Columvi in pediatric patients have not been established.

Glofitamab is a bispecific antibody, a modern class of drugs designed to target two different binding sites at once.

Columvi binds to T cells, a type of immune cell, as well as B cells, including cancerous B cells, bringing T cells and B cells close together. This enables T cells to release cytokines, which attack and kill malignant B cells. While this mechanism is effective against cancer cells, it may also reduce healthy B cells in the body.

Glofitamab (Columvi) represents a breakthrough in immuno-oncology, offering hope to patients with relapsed or refractory large B-cell lymphomas. Though not yet registered for sale in India, patients can still buy Glofitamab in India through authorized import programs with proper documentation.

The process to import Glofitamab in India requires a doctor’s prescription, diagnostic confirmation, and regulatory approvals. Through reliable licensed providers, patients can ensure safe and timely access to treatment. For families and caregivers seeking assistance, expert support is available to guide them on its latest availability in India and the most updated pricing options.

Pricing:

The Glofitamab price in India is not fixed since it is not yet registered for commercial distribution in India. The cost varies depending on the supplier’s country, shipping charges, and duration of treatment. Patients seeking to buy Glofitamab in India must go through authorized import channels.

Columvi is only available by prescription, and price quotes are provided after review of medical documents. Patients and caregivers can contact 247QualityMeds, an authorized import facilitator, for up-to-date pricing and guidance.

Steps to Import Columvi (glofitamab):

Since Columvi is not marketed in India through local pharmacies, it can be accessed via the Named Patient Import Program (NPIP).

Documents required to import Columvi (glofitamab) into India:

A valid prescription from a qualified oncologist.
Patient’s diagnostic test reports confirming DLBCL or LBCL.
Government-issued patient ID proof.
Import permit (if applicable).

Order confirmation process:

Orders are confirmed only after a valid prescription and required documents are submitted.

Following approval, Columvi is sourced from licensed international distributors and shipped securely to India.

This regulated process ensures patients can import Glofitamab India safely and legally.

Access Information:

Glofitamab availability in India is facilitated by licensed providers who import the medicine under patient-specific authorization. It is not sold at local chemists or retail pharmacies, but through approved channels, it can be delivered to major cities such as Delhi, Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Bangalore, Pune, Chandigarh, Jaipur, Lucknow, and others.

Key highlights of availability:

Supplied only against a prescription.
Sourced from genuine suppliers in the USA, Canada, Europe, or Australia.
Ensures 100% transparency in cost and supply.
Prescriptions are reviewed by registered pharmacists before dispatch.

Columvi can also be facilitated for patients worldwide, not just in India, provided all legal requirements are met. Patients with limited treatment options can benefit from advanced therapies like Columvi (Glofitamab). For clear guidance on Glofitamab availability and price in India, and to safely buy Columvi, patients and caregivers can rely on 24/7QualityMeds for trusted support.

by 24/7QualityMeds

September 30, 2025

Elosulfase alfa, marketed under the brand name Vimizim™, is a recombinant form of the enzyme N-acetylgalactosamine-6-sulfatase, manufactured by BioMarin Pharmaceutical Inc. and approved by the US FDA in 2014 for the treatment of Mucopolysaccharidosis type IVA (MPS IVA), also known as Morquio A Syndrome.

Patients with MPS IVA lack sufficient levels of N-acetylgalactosamine-6-sulfatase, leading to the accumulation of glycosaminoglycans (GAGs) in the lysosomes, which causes progressive damage to multiple tissues and organs. Vimizim (elosulfase alfa) replaces the deficient enzyme, enabling the breakdown of GAG substrates such as keratan sulfate (KS) and chondroitin-6-sulfate (C6S).

The drug is supplied in 5 mg/5 mL vials and administered at a recommended dose of 2 mg/kg once weekly, as an intravenous infusion over 3.5 to 4.5 hours.

Elosulfase alfa mimics the function of the natural human enzyme and is targeted for uptake into lysosomes through mannose-6-phosphate receptors. Inside lysosomes, the drug enhances the breakdown of stored glycosaminoglycans, thereby reducing their toxic accumulation.

In preclinical studies using human chondrocytes derived from MPS IVA patients, elosulfase alfa demonstrated significant clearance of lysosomal KS deposits.

Elosulfase alfa (Vimizim) is a life-changing therapy for patients with Morquio A Syndrome (MPS IVA). Though not locally registered, Indian patients can legally buy elosulfase alfa India through authorized import routes. By following the required documentation and regulatory steps, patients gain access to this vital treatment.

With assistance from licensed facilitators, patients and caregivers can smoothly manage the import elosulfase alfa India process. For those seeking reliable supply and updated elosulfase alfa availability India, expert support ensures timely access, transparent pricing, and authentic sourcing.

Pricing:

Elosulfase alfa price India is variable since the drug is not registered for commercial sale in India. The cost depends on the supplier, country of origin, shipping, and documentation. Patients or caregivers can buy elosulfase alfa India legally through special import channels.

Since this is a prescription-only therapy, the price quotation for Vimizim 5 mg/5 mL injection is provided upon request, after submission of valid medical documents. For updated pricing and procurement details, contact: +919967979080 or visit: 247QualityMeds.com

Import Steps:

As Vimizim (elosulfase alfa) is not commercially registered in India, it can only be accessed through the Named Patient Import Program (NPIP).

Documents required to import Vimizim (elosulfase alfa) into India:

Valid prescription from a qualified doctor.
Diagnostic reports confirming MPS IVA.
Government-issued patient ID proof.
Import permit (if applicable).

Order confirmation process:

Order is finalized only after submission of a valid prescription and necessary documents.
Once the import permit is approved, the licensed supplier arranges shipment of Vimizim from the USA, Canada, Europe, or Australia.

With these steps, patients can import elosulfase alfa India safely and legally.

Access Information:

Elosulfase alfa availability India is made possible through authorized import facilitators such as Indian Pharma Network (IPN), which assists in procuring medicines for patients under the Named Patient Supply (NPS) route.

Available in major Indian cities including Mumbai, Delhi, Kolkata, Hyderabad, Chennai, Ahmedabad, Bangalore, Pune, Chandigarh, Jaipur, Srinagar, Goa, Lucknow, and more.
Medicines are sourced only from genuine international suppliers to ensure safety and authenticity.
100% transparency in pricing and supply is guaranteed.
Prescriptions are dispensed and checked by registered pharmacists before delivery to patients.

Additionally, IPN can facilitate global delivery of Vimizim, making the drug accessible not only in India but also in overseas countries where it may not be readily available.

Elosulfase alfa (Vimizim) offers hope for patients with Morquio A Syndrome (MPS IVA) by addressing the underlying enzyme deficiency and helping improve quality of life. While it is not commercially registered in India, patients can access this therapy safely through authorized import programs. For timely access, transparent pricing, and professional assistance, patients and caregivers can buy Elosulfase alfa in India at 247QualityMeds.com.

by 24/7QualityMeds

September 29, 2025

Blincyto is a prescription medicine with the active ingredient blinatumomab (API). It belongs to the class of monoclonal antibodies and is categorized under bispecific T-cell engagers (BiTEs). This advanced immunotherapy drug is approved by the US FDA for the treatment of patients with B-cell precursor acute lymphoblastic leukemia (ALL). Blincyto is available in vials containing 38.5 mcg and 35 mcg of lyophilized powder.

The drug works by engaging and activating T-cells, enabling them to target and destroy CD19-positive B-cells, including malignant leukemia cells. By forming a synapse between T-cells and tumor cells, it triggers the release of cytolytic proteins, cytokines, and promotes T-cell proliferation, ultimately leading to the destruction of leukemia cells.

Blincyto (Blinatumomab) is manufactured using CHO (Chinese hamster ovary) cell lines and represents one of the most innovative approaches in modern hematology.

Blincyto (blinatumomab) is a breakthrough immunotherapy option for patients suffering from acute lymphoblastic leukemia (ALL). While the drug is not yet registered in India, it is legally accessible via import blinatumomab India programs. Patients can safely buy blinatumomab in India through authorized suppliers with proper medical prescription and regulatory support.

For updated details on blinatumomab availability India and assistance in securing the best Blincyto price in India, patients and caregivers are encouraged to connect with licensed sourcing experts.

Medical Uses of Blinatumomab

Blincyto (blinatumomab) is indicated for the treatment of:

CD19-positive B-cell precursor ALL in adult and pediatric patients (≥1 month old) in first or second complete remission with minimal residual disease (MRD ≥0.1%).
Relapsed or refractory CD19-positive B-cell precursor ALL in both adults and children.
Philadelphia chromosome-negative CD19-positive B-cell precursor ALL in the consolidation phase of multiphase chemotherapy.

Blincyto infusion is prepared by mixing the powder with a sterile liquid. It is administered as an intravenous (IV) infusion by a trained healthcare provider in a hospital, clinic, or at home under supervision.

Pricing:

Blincyto 38.5 mcg Injection in India is usually prescribed by hematologists and oncologists, especially for patients who are candidates for bone marrow transplant (BMT). However, Blincyto is not registered in India and is not readily available through local pharmacies or standard distribution networks.

Indian patients can buy Blincyto in India through the Named Patient Import License route, which allows access to unregistered drugs for personal medical use. The cost of Blincyto in India may vary, and patients are advised to seek expert guidance for reliable sourcing.

Blincyto is manufactured and promoted by Amgen and may also be referred to by its generic name, blinatumomab. Since it is an imported drug, the Blincyto price in India depends on international supplier costs, shipping, and authorization processes.

Patients, physicians, and hospitals may consult licensed importers to buy blinatumomab in India at the best available price. For updated pricing information and purchase support, contact:

Import Steps:

Since Blincyto is not commercially registered in India, patients must use the legal Named Patient Import Program to obtain it. The process involves:

Doctor’s Prescription – A treating hematologist/oncologist must prescribe Blincyto for the patient.
Application for Import – Patients or caregivers apply for a Named Patient Import License through India’s regulatory authority.
Authorization and Procurement – A licensed supplier arranges for the legal import of Blincyto from authorized international sources.
Delivery – The medicine is shipped securely to major Indian cities such as Delhi, Mumbai, Bangalore, Kolkata, Hyderabad, Chennai, Pune, Ahmedabad, and others.

This ensures that import of blinatumomab India is safe, legal, and compliant with health regulations.

Access Information:

As Blincyto is not marketed in India through regular distribution, patients can access it only via special import channels. Licensed providers and import facilitators ensure that blinatumomab availability in India is maintained for patients in need.

Blincyto (blinatumomab) can be made available not only across major Indian cities but also in overseas regions like the UK, UAE, Turkey, and Egypt. Patients who require urgent access can benefit from expert assistance in handling documentation, sourcing, and customs clearance.

With proper medical prescription and regulatory approvals, patients can buy Blincyto injection in India legally and access the therapy without unnecessary delays.

To buy Blincyto in India or know the latest Blincyto price, visit 24/7qualitymeds.com for trusted guidance and secure ordering.